OBJECTIVE: Serological evaluation of herpes simplex virus infections during pregnancy. METHODS: 2991 serum samples were obtained during 1st, 2nd, and 3rd trimester from 997 pregnant women. Baculovirus expressed glycoproteins gG1 (HSV-1) and gG2 (HSV-2) were used as antigens in ELISA for HSV-1 and HSV-2 IgG and IgA antibodies. RESULTS: The prevalence of HSV-1 gG1 antibodies was 70% and that of HSV-2 gG2 antibodies 16%. Among susceptible women we found five (0.6%) cases with serological evidence of primary HSV-2 infection during pregnancy. Evidence of active HSV-1 infection was found in nine (0.9%) cases. Decline of HSV-2 gG2 IgG antibody levels during pregnancy was pronounced compared with HSV-1 gG1 IgG antibody levels (p < 0.01); also the proportion of seroreversions was considerably higher among HSV-2 seropositives (25%) than among HSV-1 seropositives (3%) (p < 0.001). CONCLUSIONS: HSV-2 gG2 IgG antibodies were readily distinguished from HSV-1 gG1 IgG antibodies by the glycoprotein gG ELISAs. Serological assays for gG2 antibodies should guard against the decline of specific antibodies during pregnancy.
OBJECTIVE: Serological evaluation of herpes simplex virus infections during pregnancy. METHODS: 2991 serum samples were obtained during 1st, 2nd, and 3rd trimester from 997 pregnant women. Baculovirus expressed glycoproteins gG1 (HSV-1) and gG2 (HSV-2) were used as antigens in ELISA for HSV-1 and HSV-2 IgG and IgA antibodies. RESULTS: The prevalence of HSV-1 gG1 antibodies was 70% and that of HSV-2 gG2 antibodies 16%. Among susceptible women we found five (0.6%) cases with serological evidence of primary HSV-2 infection during pregnancy. Evidence of active HSV-1 infection was found in nine (0.9%) cases. Decline of HSV-2 gG2 IgG antibody levels during pregnancy was pronounced compared with HSV-1 gG1 IgG antibody levels (p < 0.01); also the proportion of seroreversions was considerably higher among HSV-2 seropositives (25%) than among HSV-1 seropositives (3%) (p < 0.001). CONCLUSIONS:HSV-2 gG2 IgG antibodies were readily distinguished from HSV-1 gG1 IgG antibodies by the glycoprotein gG ELISAs. Serological assays for gG2 antibodies should guard against the decline of specific antibodies during pregnancy.
Authors: W M Sullender; L L Yasukawa; M Schwartz; L Pereira; P A Hensleigh; C G Prober; A M Arvin Journal: J Infect Dis Date: 1988-01 Impact factor: 5.226
Authors: A M Arvin; P A Hensleigh; C G Prober; D S Au; L L Yasukawa; A E Wittek; P E Palumbo; S G Paryani; A S Yeager Journal: N Engl J Med Date: 1986-09-25 Impact factor: 91.245
Authors: J N Bavinck; L Gissmann; F H Claas; F J Van der Woude; G G Persijn; J Ter Schegget; B J Vermeer; I Jochmus; M Müller; G Steger Journal: J Immunol Date: 1993-08-01 Impact factor: 5.422
Authors: R Whitley; A Arvin; C Prober; L Corey; S Burchett; S Plotkin; S Starr; R Jacobs; D Powell; A Nahmias Journal: N Engl J Med Date: 1991-02-14 Impact factor: 91.245
Authors: A Mindel; J Taylor; R L Tideman; C Seifert; G Berry; K Wagner; J Page; C Marks; B Trudinger; A Cunningham Journal: Sex Transm Infect Date: 2000-08 Impact factor: 3.519
Authors: Keely Cheslack-Postava; Alan S Brown; Roshan Chudal; Auli Suominen; Jukka Huttunen; Helja-Marja Surcel; Andre Sourander Journal: Schizophr Res Date: 2015-05-26 Impact factor: 4.939